CAS 469-21-6
:(±)-Doxylamin
- (.+-.)-Doxylamine
- 2-[α-[2-(Dimethylamino)ethoxy]-α-methylbenzyl]pyridine
- Donormil
- Doxilminio
- Doxylamin
- Ls 127
- N,N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine
- Pyridine, 2-[α-[2-(dimethylamino)ethoxy]-α-methylbenzyl]-
- Ethanamine, N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-
- dimethyl(2-(1-phenyl-1-(2-pyridyl)ethoxy)ethyl)amine
- alpha-Dimethylaminoethoxyphenylmethyl-2-picoline
- 2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine
- Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether
- phenyl-2-pyridylmethyl-b-N,N-dimethylaminoethyl ether
- Pyridine, 2-[alpha-[2-(dimethylamino)ethoxy]-alpha-methylbenzyl]-
- DOXYLAMINE USP/EP/BP
- 2-dimethylaminoethoxyphenylmethyl-2-picoline
- NCI C60684
- oxylamine
- Doxylamine Hydrogen inate
- Weitere Synonyme anzeigen
Doxylamine Succinate
CAS:Formel:C17H22N2O·C4H6O4Reinheit:>98.0%(T)(HPLC)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:388.46S-Doxylamine
CAS:Kontrolliertes ProduktApplications S-Doxylamine is a first-generation antihistamine and a sedative. Doxylamine is used to treat nausea and vomiting of pregnancy. Overdose of Doxylamine can cause rhabdomyolysis.
References Cantrell, F.L., et al.: Clin. Toxicol., 53, 178 (2015); Choi, H., et al.: Yakhak Hoechi, 59, 230 (2015); Koren, G., et al.: BMC Pregnancy Childbirth, 15, 1 (2015); Jo, Y., et al.: Hum Exp Toxicol., 26, 617 (2007)Formel:C17H22N2OFarbe und Form:NeatMolekulargewicht:270.37(±)-Doxylamine
CAS:Kontrolliertes ProduktStability Temperature Sensitive
Applications (±)-Doxylamine is an intermediate in the synthesis of Doxylamine N, N’-Dioxide (D562025), which is an impurity of Doxylamine (succinate salt, D562000), which is an H1 Histamine receptor antagonist.
References Sjoqvist, F., et al.: Clin. Pharmacol. Ther., 8, 48 (1967), Eccles, R., et al.: J. Pharm. Pharmacol., 47, 990 (1995)Formel:C17H22N2OFarbe und Form:NeatMolekulargewicht:270.37


